Exploring the therapeutic role of thiabendazole in lung adenocarcinoma via network pharmacology and single-cell analysis
Thiabendazole demonstrates promising anticancer potential in LUAD, influencing key genes and immune pathways. It may serve as an effective therapeutic agent targeting both cancer cells and the tumor microenvironment.
Authors
- Chunlin Ye (ORCID: https://orcid.org/0000-0002-7561-9989)
- Wanghong Qi
- Guoqiu Xu (ORCID: https://orcid.org/0009-0008-8905-4369)
- Xiancong Liu (ORCID: https://orcid.org/0000-0002-1927-5245)
- Lang Tang
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1016/j.tranon.2025.102548
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00